Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Japanese Encephalitis Virus Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02492165
What this trial is testing

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 250
Large-scale testing (Phase 3)Study completedNCT01041573
What this trial is testing

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Who this might be right for
Encephalitis
Valneva Austria GmbH 1,869
Post-approval studies (Phase 4)UnknownNCT01954810
What this trial is testing

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

Who this might be right for
Japanese Encephalitis
Khon Kaen University 88
Post-approval studies (Phase 4)Study completedNCT02526550
What this trial is testing

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

Who this might be right for
Encephalitis
Siriraj Hospital 50
Not applicableStudy completedNCT06372665
What this trial is testing

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

Who this might be right for
Japanese Encephalitis
Liaoning Chengda Biotechnology CO., LTD 15,357
Large-scale testing (Phase 3)Study completedNCT00595465
What this trial is testing

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 389
Post-approval studies (Phase 4)Study completedNCT06331702
What this trial is testing

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Liaoning Chengda Biotechnology CO., LTD 408
Large-scale testing (Phase 3)Study completedNCT01188343
What this trial is testing

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Sanofi Pasteur, a Sanofi Company 542
Not applicableUnknownNCT01163123
What this trial is testing

Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan

Who this might be right for
Japanese Encephalitis
Mennonite Christian Hospital 312
Testing effectiveness (Phase 2)Study completedNCT00982137
What this trial is testing

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

Who this might be right for
Japanese EncephalitisYellow Fever
Sanofi 108
Not applicableStudy completedNCT03920111
What this trial is testing

Flavivirus Cross-priming Potential of IMOJEV

Who this might be right for
Japanese Encephalitis
University of Liverpool 19
Large-scale testing (Phase 3)Study completedNCT01466387
What this trial is testing

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Who this might be right for
Meningococcal DiseaseMeningococcal MeningitisTyphoid+3 more
Novartis 552
Testing effectiveness (Phase 2)Study completedNCT06680128
What this trial is testing

Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Who this might be right for
Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd. 161
Large-scale testing (Phase 3)Study completedNCT00735644
What this trial is testing

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

Who this might be right for
Japanese EncephalitisHepatitis A
Sanofi Pasteur, a Sanofi Company 1,200
Large-scale testing (Phase 3)UnknownNCT04223037
What this trial is testing

Purified Inactivated Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis Virus Disease
Chinese Academy of Medical Sciences 1,050
Post-approval studies (Phase 4)UnknownNCT03971058
What this trial is testing

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

Who this might be right for
Japanese Encephalitis Vaccine
Medical University of Vienna 64
Not applicableStudy completedNCT02602652
What this trial is testing

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Who this might be right for
Japanese Encephalitis
Chulalongkorn University 50
Testing effectiveness (Phase 2)Study completedNCT00703521
What this trial is testing

Rabies Immunization Concomitant With JEV in Children

Who this might be right for
Rabies
Mahidol University 200
Post-approval studies (Phase 4)Study completedNCT02514746
What this trial is testing

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Who this might be right for
Encephalitis, Japanese
PATH 561
Post-approval studies (Phase 4)Study completedNCT01656200
What this trial is testing

A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

Who this might be right for
Japanese EncephalitisJapanese Encephalitis Vaccine
Indian Institute of Science 17
Next Page